FDA Rejects Disc Medicine's Drug for Rare Sunlight Sensitivity Disorder, Shares Plunge
Disc Medicine's bitopertin gets turned down by FDA for treating EPP, a painful genetic condition making skin ultra-sensitive to sun.
Feed↓
/ What's going on?
Filter:
ICE's $38.3B Plan: Turning Warehouses into Massive Immigrant Detention Centers
ICE plans to spend $38.3 billion converting warehouses nationwide—including one near Hagerstown, MD—into large detention facilities for mass deportations. Companies like CoreCivic and GEO Group stand to benefit from the immigration detention boom.
Reddit Insider Buy Signals Potential Bottom?
Reddit stock down ~46% YTD in 2026, but Director Sarah Farrell's $7.48M purchase of 50,500 shares shows strong conviction amid the sell-off. Could this spark a rebound?
Plug Power Secures Shareholder Nod to Double Share Count, Dodging Reverse Split Drama
Plug Power gains approval to increase authorized shares from 1.5B to 3B, enabling fresh funding rounds without a reverse split—key for growth in hydrogen tech amid data center power surge.
Airbnb Roars Back – 12% Revenue Jump and Bullish 2026 Outlook Lift Shares
Airbnb delivers impressive Q4 results with 12% revenue growth, beating expectations, and forecasts 14-16% Q1 2026 revenue increase amid rising travel demand and new features.
Craig-Hallum Bullish on Compass Therapeutics: Buy Rating & $15 Target
Investment firm Craig-Hallum starts coverage on Compass Therapeutics with a Buy rating and $15 price target, highlighting its promising bispecific antibody pipeline and potential blockbuster in biliary tract cancer.